SeminarRecording AvailableNeuroscience

Mechanisms of CACNA1A-associated developmental epileptic encephalopathies

Schedule
Wednesday, November 3, 2021
16:00 UTC
Elsa Rossignol

Prof

University of Montreal

Host: Clinical and Experimental Epilepsy

Recording

Event Information

Recording

Available

Host

Clinical and Experimental Epilepsy

Duration

70 minutes

Abstract

Developmental epileptic encephalopathies are early-onset epilepsies, often refractory to therapy, with developmental delay or regression. These disorders carry poor neurodevelopmental prognosis, with long-term refractory epilepsy and persistent cognitive, behavioral and motor deficits. Mutations in the CACNA1A gene, encoding the pore-forming α1 subunit of CaV2.1 voltage-gated calcium channels, result in a spectrum of neurological disorders, including severe, early-onset epileptic encephalopathies. Recent work from the Rossignol lab helped characterize the phenotypic spectrum of CACNA1A-related epilepsies in humans. Using conditional genetics and novel animal models, the Rossignol lab unveiled some of the underlying pathophysiological mechanisms, including critical deficits in cortical inhibition, resulting in seizures and a range of cognitive-behavioral deficits. Importantly, Dr. Rossignol’s team demonstrated that the targeted activation of specific GABAergic interneuron populations in selected cortical regions prevents motor seizures and reverts attention deficits and cognitive rigidity in mouse models of the disorder. These recent findings open novel avenues for the treatment of these severe CACNA1A-associated neurodevelopmental disorders.

We use essential cookies to run the site. Analytics cookies are optional and help us improve World Wide. Learn more.